a-L-xylo-3-Hexulofuranosonic acid,2-C-[(1-ethyl-1H-indol-3-yl)methyl]-, g-lactone (9CI) (110326-15-3)

Identification
Name:	a-L-xylo-3-Hexulofuranosonic acid,2-C-[(1-ethyl-1H-indol-3-yl)methyl]-, g-lactone (9CI)
Synonyms:	Furo[3,2-b]furan,a-L-xylo-3-hexulofuranosonic acidderiv.
CAS:	110326-15-3
Molecular Formula:	C17H19 N O6
Molecular Weight:	0
InChI:	InChI=1/C17H19NO6/c1-2-18-9-11(13-5-3-4-6-14(13)18)7-16(22,15(20)21)17(23)8-12(19)10-24-17/h2-6,9,12,19,22-23H,1,7-8,10H2,(H,20,21)/t12-,16-,17+/m1/s1
Molecular Structure:
Properties
Flash Point:	277.1°C
Boiling Point:	534.6°C at 760 mmHg
Density:	1.42g/cm³
Refractive index:	1.633
Flash Point:	277.1°C
Safety Data

Other Product

a-L-xylo-3-Hexulofuranosonic acid,2-C-[(1-methyl-1H-indol-3-yl)methyl]-, g-lactone (9CI)
a-L-xylo-3-Hexulofuranosonic acid,2-C-(1H-indol-3-ylmethyl)-, g-lactone (9CI)
a-L-xylo-3-Hexulofuranosonic acid,2-C-[(2,3-dibromo-4,5-dihydroxyphenyl)methyl]-, g-lactone (9CI)
a-L-lyxo-3-Hexulofuranosonic acid,2-C-(1H-indol-3-ylmethyl)-, g-lactone (9CI)
alpha-L-lyxo-3-Hexulofuranosonic acid, 2-C-(1H-indol-3-ylmethyl)-, gamma-lactone, mixt. with 2-C-(1H-indol-3-ylmethyl)-alpha-L-xylo-3-hexulofuranosonic acid gamma-lactone
2,5-Pyrrolidinedione, compd with 2-C-(5-methyl-2-furanyl)-alpha-L-xylo-3-hexulofuranosonic acid gamma-lactone (1:2)
â-L-threo-L-glycero-3-Hexulofuranosonic acid,2-C-[(4-hydroxyphenyl)methyl]-2-Omethyl-,ç-lactone
a-L-xylo-3-Hexulofuranosidonicacid, b-D-glucopyranosyl2-C-[(1R)-1-(4-hydroxyphenyl)-3-methoxy-3-oxopropyl]-, g-lactone (9CI)
a-L-xylo-3-Hexulofuranosidonicacid, b-D-glucopyranosyl2-C-[(1R)-2-carboxy-1-(4-hydroxyphenyl)ethyl]-, 1,4-lactone (9CI)
L-Arabinonic acid,2,5-dideoxy-2-methyl-3-C-[[[(1R,7aR)-1-(acetyloxy)-2,3,5,7a-tetrahydro-1H-pyrrolizin-7-yl]methoxy]carbonyl]-,g-lactone (9CI)
L-xylo-Heptonic acid,2,3,5,6,7-pentadeoxy-3,6-epidioxy-4-C-methyl-6-C-(10-phenyldecyl)-, g-lactone (9CI)
L-xylo-Heptonic acid,3,6-anhydro-2,5,7- trideoxy-5-[[(3S,3aS,8bR)-3-(3-furanyl)-4,5- dihydro-1-oxo-1H,3H-3a,8b-methanobenzo[1,- 2-b:3,4-c']difuran-7-yl]methyl]-4,6-di-Cmethyl-,ç-lactone
L-xylo-Heptonic acid,3,6-anhydro-2,5,7- trideoxy-5-[[(3R,3aS,8bR)-3-(3-furanyl)-4,5- dihydro-1-oxo-1H,3H-3a,8b-methanobenzo[1,- 2-b:3,4-c']difuran-7-yl]methyl]-4,6-di-Cmethyl-,ç-lactone
L-xylo-Heptonic acid,3,6-anhydro-2,5,7- trideoxy-5-[3-[(1R,3aS,4R,7aS)-1-(3- furanyl)tetrahydro-3,5-dioxo-1H,3H-3a,7amethanoisobenzofuran- 4-yl]-2-oxopropyl]-4,- 6-di-C-methyl-,ç-lactone
a-L-threo-3-Hexulofuranosonicacid, 2-C-(1H-indol-3-ylmethyl)-, g-lactone, (2x)-
L-xylo-Heptonic acid,3,6-anhydro-2,5,7- trideoxy-5-[[(1R,3R,3aS,8bR)-3-(3-furanyl)- 4,5-dihydro-1-hydroxy-1H,3H-3a,8bmethanobenzo[ 1,2-b:3,4-c']difuran-7-yl]- methyl]-4,6-di-C-methyl-,ç-lactone
a-L-xylo-2-Hexulofuranosonic acid,2,3:4,6-bis-O-(1-methylethylidene)-, sodium salt (1:1)
a-L-xylo-2-Hexulofuranosonic acid,2,3:4,6-bis-O-(1-methylethylidene)-, hydrate (1:1)
a-L-xylo-2-Hexulofuranosonic acid,2,3:4,6-bis-O-(1-methylethylidene)-
D-xylo-Hexaric acid,3,4-dideoxy-2-C-ethyl-4-methyl-5-C-methyl-, 1,5-lactone (9CI)